Iridium complex, method for manufacturing same, and organic light-emitting devices using same

Abstract

An iridium complex is disclosed. The iridium complex includes two primary ligands selected from 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyrimidine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyrimidine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyrazine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyrazine, and the derivatives of 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butytriazine and 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butytriazine. The iridium complex further includes an auxiliary acetylacetone ligand. Such new iridium complex in the invention not only owns the high luminous efficiency, stable chemical property, easy sublimation purification and is other advantages, but also has good device performance. By embellishing the molecular structure of the primary ligand, it could adjust the light intensity and efficiency of complexes within the scope of green light wavelength, which provides the convenience for the design and production of organic light emitting device and lighting source.

Claims

1. An iridium complex including two primary ligands selected from one of 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyrimidine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyrimidine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyrazine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyrazine, and the derivatives of 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butytriazine and 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butytriazine, and an auxiliary acetylancetone ligand; wherein the pyridine derivatives which coordinates with iridium by C atom is: ##STR00014## connection locations between the pyridine, pyrimidine and pyrazine in the mentioned pyrimidine derivatives and the primary ligand and the triazine derivatives are different, arbitrary bit of the mentioned pyridine, pyrimidine, pyrazine and triazine derivatives is replaced by halogen or alkyl group, the quantity of substituent group on the mentioned pyridyl is 0-4, the quantity of substituent group on the mentioned pyrimidine and pyrazinyl is 0-3, and the quantity of substituent group on the mentioned triazinyl is 0-2.

2. The iridium complex as described in claim 1, wherein the mentioned halogen is F, and the mentioned alkyl group is any one of trifluoromethyl and methyl.

3. The iridium complex as described in claim 2, wherein the substitution position of the mentioned 4,6-difluoromethyl and trifluoromethyl pyridine is bit 3 or bit 4, and the mentioned pyridine, pyrimidine, pyrazine and triazine derivatives are selected from one of: ##STR00015##

4. The iridium complex as described in claim 3, wherein the mentioned iridium complex includes one of the following structures: ##STR00016## ##STR00017## ##STR00018## ##STR00019## ##STR00020## ##STR00021## ##STR00022## ##STR00023## ##STR00024##

5. A method for manufacturing an iridium complex as described in claim 1, the method including: mixing iridium dimerization bridging complex including two primary ligands, auxiliary acetylacetone ligand and sodium carbonate, wherein the mentioned primary ligands are the follows: 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyrimidine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyrimidine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyrazine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyrazine, and the derivatives of 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butytriazine and 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butytriazine; adding 2-ethoxyethanol solution and heating at 120- 140° C. for 12-48 h, then cooling down to the room temperature; removing the solvent by decompression and distillation; extracting and concentrate with dichloromethane; gaining the crude product of complexes by column chromatography isolation, and gaining pure iridium complex through sublimation.

6. The method as described in claim 5, wherein the mole ratio of mentioned Iridium dimer bridging complexes, the acetylacetone, and sodium carbonate is 1:2:5.

7. An organic light-emitting device, including a substrate made of glass, an anode of indium tin oxide, a hole transport layer, an organic light emitting layer and an electron transfer layer and a cathode; wherein the hole transport layer is made of TAPC materials, the electron transfer layer is made from TmPyPB materials, and the organic light emitting layer includes host materials and light-emitting materials, in which, the host material is 1,3-bi (9H-carbazole-9-buty) benzene mCP, and the light-emitting material is the iridium complex as described in claim 1.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0008] FIG. 1 is an electroluminescent spectra of an iridium complex GIr2-001 used in an organic light-emitting device;

[0009] FIG. 2 is an photoelectric property of the iridium complex GIr2-001 used in the organic light-emitting device; and

[0010] FIG. 3 is an photoelectric property that the iridium complex GIr2-001 used in the organic light-emitting device.

DETAILED DESCRIPTION OF THE EXEMPLARY EMBODIMENT

[0011] The present disclosure will hereinafter be described in detail with reference to an exemplary embodiment. To make the technical problems to be solved, technical solutions and beneficial effects of the present disclosure more apparent, the present disclosure is described in further detail together with the figure and the embodiment. It should be understood the specific embodiment described hereby is only to explain the disclosure, not intended to limit the disclosure.

[0012] An iridium complex includes two primary ligands with an acetylacetone auxiliary ligand, and the mentioned primary ligand is any one in 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyrimidine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyrimidine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyrazine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyrazine, and the derivatives of 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butytriazine and 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butytriazine. In the primary ligand, the pyridine derivatives which coordinates with iridium by C atom is:

##STR00001##

the connection locations between the pyridine, pyrimidine and pyrazine in the mentioned triazine derivatives and the primary ligand and the triazine derivatives are different, arbitrary bit of the mentioned pyridine, pyrimidine, pyrazine and triazine derivatives is replaced by halogen or alkyl group, the quantity of substituent group on the mentioned pyridyl is 0-4, the quantity of substituent group on the mentioned pyrimidine and pyrazinyl is 0-3, and the quantity of substituent group on the mentioned triazinyl is 0-2. Among them, the mentioned halogen is F, and the mentioned alkyl group is any one of trifluoromethyl and methyl. The replacement position of 4,6-difluoromethyl and trifluoromethyl pyridine of the primary ligand is 3-bit or 4-bit, and the mentioned pyridine, pyrimidine, pyrazine and triazine derivatives are selected from:

##STR00002##

any one from them.

[0013] In the synthetic process of iridium complex in the invention, the Iridium trichloride, 4,6-difluoromethyl and trifluoromethyl pyridine-3 boracic acid, 4,6-difluoromethyl and trifluoromethyl pyridine-4-boracic acid, 2-Bromide pyridine derivatives, 2-Bromine pyrimidine derivatives, 2-Bromine pyrazine derivatives and 2-Bromine triazine derivatives with the similar synthesis methods.

[0014] Take 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyrimidine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyrimidine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyrazine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyrazine, and the derivatives of 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butytriazine and 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butytriazine as mixture of the ligand of iridium dimerization bridging complexes and the auxiliary acetylacetone ligand and the sodium carbonate; 2-ethoxyethanol solution is added for the heating reaction at 120-140° C. for 12-48 h, then cool down to the room temperature, remove the solvent by decompression and distillation, then extract and concentrate with dichloromethane, finally gain the crude product of complexes by column chromatography isolation, and gain pure iridium complex through sublimation. Among them, the mentioned iridium dimerization bridging complex includes 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyrimidine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyrimidine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyrazine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyrazine, and the derivatives of 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butytriazine and 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butytriazine. The mole ratio of Iridium dimer bridging complexes, the auxiliary ligand and sodium carbonate is 1:2:5.

[0015] The mentioned iridium complex owns the one of the following structures:

##STR00003## ##STR00004## ##STR00005## ##STR00006## ##STR00007## ##STR00008## ##STR00009## ##STR00010## ##STR00011##

[0016] Based on one following example, the complex GIr2-001 is used to specially describe the invention content, which would be conducted to further undertaking the invention, but isn't limited to the invention content.

[0017] Manufacturing method of complexes GIr2-001

##STR00012##

[0018] 2-Bromine pyridine (26.39 mmol), 4,6-difluoromethyl and trifluoromethyl pyridine-3-boracic acid (31.66 mmol), (beta-4)-platinu (0.79 mmol) and sodium carbonate (60.00 mmol are dissolved in 100 mL butylene oxide with 65° C. reaction for 24 hours, then cool down and add water and dichloromethane. Finally, the main ligand (productivity is 52.24%) is gained from the organic horizon concentrating column by chromatography. Dissolve main ligand (13.08 mmol) and Iridium trichloride (6.23 mmol) in 15 mL 2-ethoxyethanol with mixture 130° C. reaction for 12 h, then add the auxiliary acetylacetone ligand (12.46 mmol) and sodium carbonate (31.15 mmol), and continue the 130° C. reaction for 24h. After the system cools down, add water and dichloromethane, then gain yellow solid GIr2-001 from the organic horizon concentrating column by chromatography with the productivity of 40%.

[0019] Nuclear magnetism and mass spectrometric characterization: .sup.1H NMR (500 MHz, CDCl3) δ8.65 (d, J=5.6 Hz, 2H), 8.03 (d, J=8.4 Hz, 2H), 7.85 (d, J=7.7 Hz, 2H), 7.36 (t, J=8.0 Hz, 2H), 7.5 (d, J=7.5 Hz, 2H), 7.44 (s, J=6.4 Hz, 1H), 1.90 (s, 6H). ESI-MS: 873.67 for [M]+ (C29H17F12IrN4O2), found: m/z 874.08 [M+1]+.

[0020] The invention takes 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyridine, 2-(4,6 -difluoromethyl and trifluoromethyl pyridine-4-) butypyridine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyrimidine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyrimidine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butypyrazine, 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butypyrazine, and the derivatives of 2-(4,6-difluoromethyl and trifluoromethyl pyridine-3-) butytriazine and 2-(4,6-difluoromethyl and trifluoromethyl pyridine-4-) butytriazine derivatives as a primary ligand, and takes acetylacetone as an auxiliary ligand, which designed a series of green-ray iridium complexes. It reaches the purpose for control of complexes shining and electronic mobility by designing ligand or complexes structure and embellishing the simple chemical substituent group on ligand.

[0021] All mentioned Nitrogen heterocycles are the group with stronger electronic transmission, which is conductive to balancing the injection and transmission of current carrier.

[0022] The mentioned iridium complex owns higher luminous efficiency and electronic mobility. After the optimization verification, it has simple preparation method with higher productivity.

[0023] Preparation of Organic Light-Emitting Device

[0024] Based on the following example that GIr2-001 (luminescent materials) is used to prepare the organic light-emitting device, the preparation of the organic light-emitting device in the invention is described. The structure of OLEDs device includes: Substrate, anode, hole transport layer, organic light emitting layer and electron transfer layer/cathode.

[0025] The substrate for the manufacturing the device in the invention is glass, and its anode materials are indium tin oxide (ITO); Hole transport layer uses the 4,4′-Cyclohexyl 2 [N,N (4-methyl phenyl) aniline (TAPC), the material in electronic transport layer uses 3,3′-(5′-(3-(pyridine-3-buty)phenyl)-[1,1′:3′,1″-triphenyl ]-3,3″-hydroxyl) bipyridine (TmPyPB) with the thickness and evaporation rate of 60 nm and 0.05 nm/s respectively; The cathode uses LiF/Al, their thicknesses are 1 nm and 100 nm respectively, and their evaporation rates are 0.01 nm/s and 0.2 nm/s respectively. Organic light emitting layer is the doping structure, main body material is 1,3-bi (9H-carbazole-9-buty) benzene (mCP), and the luminescent materials selected is GIr2-001. The thickness of luminescent layer is 40 nm, the evaporation rate is 0.05 nm/s, and the GIr2-001 mass fraction is 8%.

[0026] The structure of several materials used in the invention is as follows:

##STR00013##

[0027] The green-ray complexes are selected in the invention to prepare the organic light-emitting device. Please refer to FIGS. 1-3 together, the starting voltage of organic light-emitting device is 4.1 V, and its maximum power efficiency and current efficiency are 28.89 lm/W and 67.97 cd/A respectively. When the impressed voltage of organic light-emitting device reaches 17.4 V, its maximum power efficiency and current efficiency are 38.52 lm/w and 80.03 cd/A respectively, and the maximum luminance is 23452 cd/m2 It's indicated that such phosphorescence iridium complex with Nitrogen Heterocycles owns higher device efficiency, and owns the practical application value in the display, lighting and other fields.

[0028] The phosphor materials in the invention could be applied in emission layer of phosphorescence OLEDs as the luminescence center. And the invention could control the emitting color and efficiency of complexes by designing ligand or complexes structure and embellishing the chemical substituent group on mentioned ligand.

[0029] It is to be understood, however, that even though numerous characteristics and advantages of the present exemplary embodiment have been set forth in the foregoing description, together with details of the structures and functions of the embodiment, the disclosure is illustrative only, and changes may be made in detail, especially in matters of shape, size, and arrangement of parts within the principles of the invention to the full extent indicated by the broad general meaning of the terms where the appended claims are expressed.